3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
6
Mouth Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Tongue Neoplasms
1
Solid Tumor
1
Skin Lesion
1
Renal Colic
1
Rectal Neoplasms
1
Pregnancy, Ectopic
1
Postoperative Complications
1
Pneumonia
1
Pleural Effusion
1
Phlebitis
1
Pancreatic Neoplasms
1
Lymphoma, Primary Effusion
1
Lymphoma, B-Cell
1
Lymphoma, AIDS-Related
1
Liver Neoplasms
1
Kidney Neoplasms
1
Gastrointestinal Neoplasms
1
Cysts
1
Cholecystitis
1
Brain Neoplasms
1
Arachnodactyly
1
Abortion, Spontaneous
1
Interventions
pembrolizumab
12
Pemetrexed
9
Cisplatin
9
Nivolumab
8
Carboplatin
8
Ipilimumab
7
Cyclophosphamide
6
fludarabine
5
durvalumab
4
tremelimumab
2
Radiotherapy, Intensity-Modulated
2
Gemcitabine
2
Cerebral Decortication
2
tocilizumab
1
tislelizumab
1
tazemetostat
1
sotorasib
1
ruxolitinib
1
osimertinib
1
olaparib
1
obinutuzumab
1
naptumomab estafenatox
1
fludarabine phosphate
1
decitabine and cedazuridine drug combination
1
bintrafusp alfa protein, human
1
avelumab
1
atezolizumab
1
Tumor Burden
1
Tablets
1
Saline Solution
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mesothelioma
×
Ultrasonography
×
1 year
×
Clear all
No trials found.